Thus, it is reasonable to speculate that ATLL cells develop alternative oncogenic mechanisms by acquiring somatic alterations in the TCR/NF-κB signaling pathway while escaping immune surveillance by repressing immunogenic viral genes. This evidence concerns the gene NFKB1 and adult T-cell leukemia/lymphoma.